These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 5775711)
1. Metabolism of the glucuronide of N-hydroxy-2-acetylaminofluorene in the rat. Irving CC; Wiseman R Cancer Res; 1969 Apr; 29(4):812-6. PubMed ID: 5775711 [No Abstract] [Full Text] [Related]
2. Biliary excretion of the O-glucuronide of N-hydroxy-2-acetylamino-fluorene by the rat and rabbit. Irving CC; Wiseman R; Hill JT Cancer Res; 1967 Dec; 27(12):2309-17. PubMed ID: 6082281 [No Abstract] [Full Text] [Related]
3. Persistent binding of 2-acetylaminofluorene to rat liver DNA in vivo and consideration of the mechanism of binding of N-hydroxy-2-acetylaminofluorene to rat liver nucleic acids. Irving CC; Veazey RA Cancer Res; 1969 Oct; 29(10):1799-804. PubMed ID: 5823948 [No Abstract] [Full Text] [Related]
4. Possible role of the glucuronide conjugate in the biochemical mechanism of binding of the carcinogen N-hydroxy-2-acetylaminofluorene to rat-liver deoxyribonucleic acid in vivo. Irving CC; Veazey RA; Russell LT Chem Biol Interact; 1969 Oct; 1(1):19-26. PubMed ID: 5407052 [No Abstract] [Full Text] [Related]
5. Radioactivity in rat mammary gland after the administration of 2-acetylaminofluorene-9- 14 C and its N-hydroxy metabolite. Janss DH; Irving CC J Natl Cancer Inst; 1972 Sep; 49(3):765-71. PubMed ID: 4647496 [No Abstract] [Full Text] [Related]
6. Propylthiouracil: absorption, metabolism and excretion in the albino rat. Sitar DS; Thornhill DP J Pharmacol Exp Ther; 1972 Nov; 183(2):440-8. PubMed ID: 5083555 [No Abstract] [Full Text] [Related]
7. Metabolism and biliary excretion of N-2-fluorenylacetamide and N-hydroxy-2-fluorenylacetamide. Levine WG Life Sci II; 1971 Jul; 10(13):727-35. PubMed ID: 5561052 [No Abstract] [Full Text] [Related]
8. Metabolism of continuously fed 14C-labeled N-hydroxy-N-2-fluorenylacetamide at various intervals: effect of pituitary hormones. Shirasu Y; Grantham PH; Weisburger EK; Weisburger JH Cancer Res; 1967 May; 27(5):865-72. PubMed ID: 4290554 [No Abstract] [Full Text] [Related]
9. Stability of binding of label from N-hydroxy-N-2-fluorenylacetamide to intracellular targets, particularly deoxyribonucleic acid in rat liver. Szafarz D; Weisburger JH Cancer Res; 1969 Apr; 29(4):962-8. PubMed ID: 5813289 [No Abstract] [Full Text] [Related]
10. Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2-acetylaminofluorene with guanine in rat liver DNA in vivo. Kriek E Cancer Res; 1972 Oct; 32(10):2042-8. PubMed ID: 5080759 [No Abstract] [Full Text] [Related]
11. Reactions in vitro of some tissue nucleophiles with the glucuronide of the carcinogen N-hydroxy-2-acetylaminofluorene. Miller EC; Lotlikar PD; Miller JA; Butler BW; Irving CC; Hill JT Mol Pharmacol; 1968 Mar; 4(2):147-54. PubMed ID: 5650958 [No Abstract] [Full Text] [Related]
12. The role of an enterohepatic system in the metabolism of 17beta-estradiol-17-glucosiduronate in the human female. Musey PI; Green RN; Hobkirk R J Clin Endocrinol Metab; 1972 Sep; 35(3):448-57. PubMed ID: 5051368 [No Abstract] [Full Text] [Related]
13. On the significance and mechanism of the binding of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene to rat-liver ribonucleic acid in vivo. Irving CC; Veazey RA; Williard RF Cancer Res; 1967 Apr; 27(4):720-5. PubMed ID: 6025731 [No Abstract] [Full Text] [Related]
14. The effect of route of administration on the biliary excretion of phenolphthalein and its glucuronide. Clark AG; Cooke R J Pharm Pharmacol; 1978 Jun; 30(6):383-3. PubMed ID: 26774 [No Abstract] [Full Text] [Related]
15. Metabolism of the carcinogen N-hydroxy-N-2-fluorenylacetamide in germ-free rats. Weisburger JH; Grantham PH; Horton RE; Weisburger EK Biochem Pharmacol; 1970 Jan; 19(1):151-62. PubMed ID: 5507633 [No Abstract] [Full Text] [Related]
16. Biosynthesis and reactivity of the glucuronide of N-hydroxy-4-acetylaminobiphenyl. Irving CC; Russell LT; Kriek E Chem Biol Interact; 1972 Jun; 5(1):37-46. PubMed ID: 4337668 [No Abstract] [Full Text] [Related]
17. ENZYMATIC N-HYDROXYLATION OF THE CARCINOGEN 2-ACETYLAMINOFLUORENE AND THE METABOLISM OF N-HYDROXY-2-ACETYLAMINOFLUORENE-9-14C IN VITRO. IRVING CC J Biol Chem; 1964 May; 239():1589-96. PubMed ID: 14193833 [No Abstract] [Full Text] [Related]
18. The carinogenicity of N-hydroxy-N-2-fluorenyl-acetamide and the matabolism of N-2-fluorenyl-acetamide in Praomis (mastomys) natalensis. Yamamoto RS; Pai SR; Korzis J; Weisburger JH Br J Cancer; 1968 Dec; 22(4):769-75. PubMed ID: 4303104 [No Abstract] [Full Text] [Related]
19. DIFFERENCES IN THE METABOLISM OF N-HYDROXY-N-2-FLUORENYLACETAMIDE IN MALE AND FEMALE RATS. WEISBURGER EK; GRANTHAM PH; WEISBURGER JH Biochemistry; 1964 Jun; 3():808-12. PubMed ID: 14211620 [No Abstract] [Full Text] [Related]
20. Reaction of the glucuronide of the carcinogen N-hydroxy-2-acetylaminofluorene with nucleic acids. Irving CC; Veazey RA; Hill JT Biochim Biophys Acta; 1969 Mar; 179(1):189-98. PubMed ID: 5787643 [No Abstract] [Full Text] [Related] [Next] [New Search]